PARP-1 inhibitors DPQ and PJ-34 negatively modulate proinflammatory commitment of human glioblastoma cells

Neurochemical Research

Volumn 38, Issue 1, 2013, Pages 50-58

  Scalia, Marina ^a   Satriano, Cristina ^a   Greca, Rossana ^a   Stella, Anna Maria Giuffrida ^a   Rizzarelli, Enrico ^a   Spina Purrello, Vittoria ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

DPQ; INF ; LPS; PARP 1; PJ 34

Indexed keywords

3,4 DIHYDRO 5 [4 (1 PIPERIDINYL)BUTOXY] 1(2H) ISOQUINOLINE; ARGININE DERIVATIVE; CARNOSINE; ENZYME INHIBITOR; GAMMA INTERFERON; LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDE; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; N MONOMETHYLARGININE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; TREHALOSE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME RELEASE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; BRAIN NEOPLASMS; CARNOSINE; CELL LINE, TUMOR; CELL SURVIVAL; COLORING AGENTS; DOWN-REGULATION; FLUORESCENT ANTIBODY TECHNIQUE; GLIOBLASTOMA; HUMANS; ISOQUINOLINES; L-LACTATE DEHYDROGENASE; MICROSCOPY, CONFOCAL; NITRITES; PHENANTHRENES; PIPERIDINES; POLY(ADP-RIBOSE) POLYMERASES; TETRAZOLIUM SALTS; THIAZOLES; TREHALOSE;

EID: 84871615066     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-012-0887-x     Document Type: Article

References (45)

1. D'Amours D, Desnoyers S, Da Silva I, Poirier GG (1999) Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J 342(Pt 2):249-268
2. Hassa PO, Hottiger MO (2008) The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front Biosci 13:3046-3082
3. Hottiger MO, Hassa PO, Luscher B et al (2010) Toward a unified nomenclature for mammalian ADP-ribosyltransferases. Trends Biochem Sci 35(4):208-219
4. Ame JC, Spenlehauer C, de Murcia G (2004) The PARP superfamily. BioEssays 26:882-893
5. Citarelli M, Teotia S, Lamb RS (2010) Evolutionary history of the poly(ADP-ribose) polymerase gene family in eukaryotes. BMC Evol Biol 10:308
6. Hassa PO, Haenni SS, Elser M, Hottiger MO (2006) Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol Mol Biol Rev 70:789-829
7. Nguewa PA, Fuertes MA, Valladares B et al (2005) Poly(ADP-ribose) polymerases: homology, structural domains and functions. Novel therapeutical applications. Prog Biophys Mol Biol 88:143-172
8. Veres B, Radnai B, Gallyas F et al (2004) Regulation of kinase cascades and transcription factors by a poly(ADP-ribose) polymerase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharideinduced inflammation in mice. J Pharmacol Exp Ther 310:247-255
9. Oliver FJ, Menissier-de Murcia J, de Murcia G (1999) Poly(ADP-ribose) polymerase in the cellular response to DNA damage, apoptosis, and disease. Am J Hum Genet 64:1282-1288
10. Hassa PO, Covic M, Hasan S et al (2001) The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function. J Biol Chem 276:45588-45597
11. Ha HC, Hester LD, Snyder SH (2002) Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc Natl Acad Sci USA 99:3270-3275
12. Hassa PO, Buerki C, Lombardi C et al (2003) Transcriptional coactivation of nuclear factor-kappaB-dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1. J Biol Chem 278:45145-45153
13. Ha HC (2004) Defective transcription factor activation for proinflammatory gene expression in poly(ADPribose) polymerase 1-deficient glia. Proc Natl Acad Sci USA 101:5087-5092
14. Nakajima H, Nagaso H, Kakui N et al (2004) Critical role of the automodification of poly(ADP-ribose) polymerase-1 in nuclear factor-kappaB-dependent gene expression in primary cultured mouse glial cells. J Biol Chem 279:42774-42786
15. Hassa PO, Haenni SS, Buerki C et al (2005) Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription. J Biol Chem 280:40450-40464
16. Eliasson MJ, Sampei K, Mandir AS, Hurn PD et al (1997) Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 3:1089-1095
17. Burkart V, Wang ZQ, Radons J et al (1999) Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nat Med 5:314-319
18. Jijon HB, Churchill T, Malfair D et al (2000) Inhibition of poly (ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis. Am J Physiol Gastrointest Liver Physiol 279:G641-G651
19. Chiarugi A (2002) Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats. Br J Pharmacol 137:761-770
20. Boulares AH, Zoltoski AJ, Sherif ZA et al (2003) Gene knockout or pharmacological inhibition of poly(ADP-ribose) polymerase-1 prevents lung inflammation in a murine model of asthma. Am J Respir Cell Mol Biol 28:322-329
21. Iwashita A, Tojo N, Matsuura S et al (2004) A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2- [3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazo linone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia. J Pharmacol Exp Ther 310:425-436
22. Spina-Purrello V, Patti D, Giuffrida-Stella AM et al (2008) Parp and cell death or protection in rat primary astroglial cell cultures under LPS/IFNγ induced proinflammatory conditions. Neurochem Res 33:2583-2592
23. Lange M, Connelly D, Traber DL et al. (2010) Time course of nitric oxide synthases, nitrosative stress, and poly(ADP ribosylation) in an ovine sepsis model. Crit Care 14:R129. http://ccforum.com/content/14/4/R129
24. Vira'g L, Szabo' C (2002) The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 54:375-429
25. Underhill C, Toulmonde M, Bonnefoi H (2011) A review of PARP inhibitors: from bench to bedside. Ann Oncol 22:268-279
26. Graziani G, Szabò C (2005) Clinical perspectives of PARP inhibitors. Pharmacol Res 52:109-111
27. Jagtap P, Szabo C (2005) Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 4:421-440
28. Rouleau M, Patel A, Hendzel MJ, Kaufmann SH et al (2010) PARP inhibition: PARP1 and beyond. Nat Rev Cancer 10:293-301. doi: 10.1038/nrc2812
29. Krishnakumar Raga, Lee Kraus W (2010) The PARP Side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Mol Cell 39:8-24
30. Mazzone GL, Nistri A (2011) Effect of the PARP-1 inhibitor PJ 34 on excitotoxic damage evoked by kainate on rat spinal cord organotypic slices. Cell Mol Neurobiol 31:469-478
31. Spina-Purrello V, Giliberto S, Barresi V et al (2010) Modulation of PARP-1 and PARP-2 expression by L-carnosine and trehalose after LPS and INFγ-induced oxidative stress. Neurochem Res 35:2144-2153
32. de Murcia JM, Niedergang C, Trucco C et al (1997) Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci USA 94:7303-7307
33. Popoff I, Jijon H, Monia B et al (2002) Antisense oligonucleotides to poly(ADP-ribose) polymerase-2 ameliorate colitis in interleukin-10-deficient mice. J Pharmacol Exp Therap 303:1145-1154
34. Kofler J, Otsuka T, Zhang Z et al (2006) Differential effect of PARP-2 deletion on brain injury after focal and global cerebral ischemia. J Cereb Blood Flow Metab 26:135-141
35. Menissier de Murcia J, Ricoul M, Tartier L et al (2003) Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse. EMBO J 22:2255-2263
36. Rouleau M, McDonald D, Gagne P et al (2007) PARP-3 associates with polycomb group bodies and with components of the DNA damage repair machinery. J Cell Biochem 100:385-401
37. Phulwani NK (2008) Poly (ADP-ribose) polymerases (PARPs) 1-3 regulate astrocyte activation. J Neurochem 106(2):578-590. doi: 10.1111/j.1471-4159.2008. 05403.x
38. Zingarelli B, Salzman AL, Szabo C (1998) Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ Res 83:85-94
39. Yu Z, Kuncewicz T, Dubinsky WP et al (2006) Nitric oxide dependent negative feedback of PARP-1 transactivation of the inducible nitric-oxide synthase gene. J Biol Chem 281:9101-9109. doi: 10.1074/jbc.M511049200
40. Ehrlich W, Huser H, Kroger H (1995) Inhibition of the induction of collagenase by interleukin-1 beta in cultured rabbit synovial fibroblasts after treatment with the poly(ADP-ribose)-polymerase inhibitor 3-aminobenzamide. Rheumatol Int 15:171-172
41. Martin-Oliva D, Aguilar-Quesada R, O'Valle F et al (2006) Inhibition of poly(ADP-ribose) polymerase modulates tumor related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis. Cancer Res 66:5744-5756
42. Andreone TL, O'Connor M, Denenberg A et al (2003) Poly(ADPribose) polymerase-1 regulates activation of activator protein-1 in murine fibroblasts. J Immunol 170:2113-2120
43. Bryant HE, Schultz N, Thomas HD et al (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434:913-917
44. Toller IM, Altmeyer M, Kohler E et al (2010) Inhibition of ADP ribosylation prevents and cures Helicobacter-induced gastric preneoplasia. Cancer Res 70:5912-5922
45. Chen S, Chiu L-Y, Maa M-C et al (2011) zVAD-induced autophagic cell death requires c-Src-dependent ERK and JNK activation and reactive oxygen species generation. Autophagy 7:217-228